Essential hypertension
Conditions
Sponsors
Affiliated Hospital of Shandong University of TCM
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria of western medicine for essential hypertension and the diagnostic criteria for the syndrome of dizziness, irascibility and hyperactivity; Hypertension is grade 1, and the risk level is low; 2. Blood pressure was stable in the past 4 weeks, without the treatment of traditional Chinese medicine or proprietary Chinese medicine, without the treatment of western medicine or western medicine; 3. Between 18 and 75 years old, gender is not limited; 4. Patients who volunteer to participate in the trial and sign the informed consent and cooperate with various investigations and tests; 5. Women of child-bearing age should have a negative pregnancy test and agree to take non-drug contraceptive measures during the test period.
Exclusion criteria
Exclusion criteria: 1. With secondary hypertension, refractory hypertension, malignant hypertension, acute and subacute hypertension, white coat hypertension and unstable blood pressure; 2. Pregnant and lactating women, women of child-bearing age do not agree to use contraceptive measures during the experiment; 3. Have mental illness, can't cooperate very well; 4. The patients with serious heart disease, severe neurosis and heart, liver and kidney dysfunction confirmed by examination; 5. Severe endocrine, hematopoietic system, liver, kidney and other primary diseases, malignant tumors, mental patients. 6. With uncorrected hyperthyroidism, hypothyroidism; 7. Patients with nephrotic syndrome, diabetes mellitus and acute hepatobiliary disease; 8. People who have suffered from serious cerebrovascular accidents, heart diseases, severe trauma, major surgery and other primary diseases with unstable general conditions and poor prognosis within 6 months. 9. Cases of Data collected with other disease; Patients who are in the course of drug treatment and affect the investigational drug observer; 9. Those who have participated in clinical trials of other drugs within three months; 10. Other conditions that the researchers considered inappropriate for inclusion were eliminated.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum level;Syndrome integral;24-hour dynamic blood pressure monitoring;Ventricular brachial artery blood pressure; | — |
Secondary
| Measure | Time frame |
|---|---|
| LDL-C;Liver function;Routine blood;Renal function;triglycerides;Blood sugar;ecg;HDL-C;Routine urine;Total cholesterol; | — |
Countries
China
Contacts
Public ContactXue Yitao
Affiliated Hospital of Shandong University of TCM
Outcome results
None listed